BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 12823673)

  • 41. Transfusion-related acute lung injury (TRALI): a retrospective review of reported cases in Queensland, Australia over 20 years.
    Sivakaanthan A; Swain F; Pahn G; Goodison K; Gutta N; Holdsworth R; Baidya S; Tung JP
    Blood Transfus; 2022 Nov; 20(6):454-464. PubMed ID: 35969142
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Blood transfusion practices and blood-banking services in a Kenyan hospital.
    Lackritz EM; Ruebush TK; Zucker JR; Adungosi JE; Were JB; Campbell CC
    AIDS; 1993 Jul; 7(7):995-9. PubMed ID: 8357559
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The prevalence of leucocyte alloantibodies in blood donors from South China.
    Xia W; Ye X; Xu X; Chen D; Deng J; Chen Y; Ding H; Shao Y; Wang J; Liu J; Li H; Huang YF; Fu Y; Santoso S
    Transfus Med; 2015 Dec; 25(6):385-92. PubMed ID: 26876912
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Ten years of hemovigilance reports of transfusion-related acute lung injury in the United Kingdom and the impact of preferential use of male donor plasma.
    Chapman CE; Stainsby D; Jones H; Love E; Massey E; Win N; Navarrete C; Lucas G; Soni N; Morgan C; Choo L; Cohen H; Williamson LM;
    Transfusion; 2009 Mar; 49(3):440-52. PubMed ID: 18980623
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Transfusion-related acute lung injury caused by two donors with anti-human leucocyte antigen class II antibodies: a look-back investigation.
    Nicolle AL; Chapman CE; Carter V; Wallis JP
    Transfus Med; 2004 Jun; 14(3):225-30. PubMed ID: 15180814
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Diagnosis of transfusion-related acute lung injury: TRALI or not TRALI?
    Fontaine MJ; Malone J; Mullins FM; Grumet FC
    Ann Clin Lab Sci; 2006; 36(1):53-8. PubMed ID: 16501237
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Testing only donors with a prior history of pregnancy or transfusion is a logical and cost-effective transfusion-related acute lung injury prevention strategy.
    Powers A; Stowell CP; Dzik WH; Saidman SL; Lee H; Makar RS
    Transfusion; 2008 Dec; 48(12):2549-58. PubMed ID: 18717778
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Transfusion-related acute lung injury: report of a clinical look-back investigation.
    Kopko PM; Marshall CS; MacKenzie MR; Holland PV; Popovsky MA
    JAMA; 2002 Apr; 287(15):1968-71. PubMed ID: 11960539
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Patient-specific transfusion-related acute lung injury.
    Muniz M; Sheldon S; Schuller RM; Young NS; Klein HG; Leitman SF; Stroncek DF
    Vox Sang; 2008 Jan; 94(1):70-3. PubMed ID: 18171330
    [TBL] [Abstract][Full Text] [Related]  

  • 50. State of the art management of transfusion-related acute lung injury (TRALI).
    Goldberg AD; Kor DJ
    Curr Pharm Des; 2012; 18(22):3273-84. PubMed ID: 22621274
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Transfusion-related acute lung injury and pulmonary edema in critically ill patients: a retrospective study.
    Rana R; Fernández-Pérez ER; Khan SA; Rana S; Winters JL; Lesnick TG; Moore SB; Gajic O
    Transfusion; 2006 Sep; 46(9):1478-83. PubMed ID: 16965572
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Transfusion-related acute lung injury: epidemiology and a prospective analysis of etiologic factors.
    Silliman CC; Boshkov LK; Mehdizadehkashi Z; Elzi DJ; Dickey WO; Podlosky L; Clarke G; Ambruso DR
    Blood; 2003 Jan; 101(2):454-62. PubMed ID: 12393667
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Conversion to low transfusion-related acute lung injury (TRALI)-risk plasma significantly reduces TRALI.
    Arinsburg SA; Skerrett DL; Karp JK; Ness PM; Jhang J; Padmanabhan A; Gibble J; Schwartz J; King KE; Cushing MM
    Transfusion; 2012 May; 52(5):946-52. PubMed ID: 22060800
    [TBL] [Abstract][Full Text] [Related]  

  • 54. AABB survey of transfusion-related acute lung injury policies and practices in the United States.
    Kopko P; Silva M; Shulman I; Kleinman S
    Transfusion; 2007 Sep; 47(9):1679-85. PubMed ID: 17725734
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Fatalities caused by TRALI.
    Holness L; Knippen MA; Simmons L; Lachenbruch PA
    Transfus Med Rev; 2004 Jul; 18(3):184-8. PubMed ID: 15248168
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Acute and transient decrease in neutrophil count in transfusion-related acute lung injury: cases at one hospital.
    Nakagawa M; Toy P
    Transfusion; 2004 Dec; 44(12):1689-94. PubMed ID: 15584981
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Establishing assay cutoffs for HLA antibody screening of apheresis donors.
    Carrick DM; Norris PJ; Endres RO; Pandey S; Kleinman SH; Wright D; Sun Y; Busch MP;
    Transfusion; 2011 Oct; 51(10):2092-101. PubMed ID: 21332726
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Anti-leucocyte antibodies in platelet apheresis donors with and without prior immunizing events: implications for TRALI prevention.
    Sigle JP; Thierbach J; Infanti L; Muriset M; Hunziker G; Chassot K; Niederhauser C; Gowland P; Holbro A; Sunic K; Buser A; Fontana S
    Vox Sang; 2013 Oct; 105(3):244-52. PubMed ID: 23773018
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Flow-cytometric approach to the prompt laboratory diagnosis of TRALI: a case report.
    Porretti L; Coluccio E; Prati D; Colombo MB; Lopa R; Tombolini P; Ambrosone A; Crespiatico L; Scalamogna M; Rebulla P
    Eur J Haematol; 2004 Oct; 73(4):295-9. PubMed ID: 15347317
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pathology consultation on transfusion-related acute lung injury (TRALI).
    Schmidt AE; Adamski J;
    Am J Clin Pathol; 2012 Oct; 138(4):498-503. PubMed ID: 23010703
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.